Global Bone Growth Stimulation Devices Market – Industry Trends and Forecast to 2030

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Global Bone Growth Stimulation Devices Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Upcoming Reports
  • Oct 2023
  • Global
  • 350 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

Global Bone Growth Stimulation Devices Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2023 –2030
Diagramm Marktgröße (Basisjahr)
USD 965.06 Million
Diagramm Marktgröße (Prognosejahr)
USD 1,397.83 Million
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Bone Growth Stimulation Devices Market, By Product (External Bone Growth Stimulators, Implanted Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators), Application (Spinal Fusion Surgeries, Delayed Union and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Other Applications), End User (Hospitals and Clinics, Home Care, Academic and Research Institutes and CROS) - Industry Trends and Forecast to 2030.

Bone Growth Stimulation Devices Market

Bone Growth Stimulation Devices Market Analysis and Size

The medical devices that improve the fracture healing process in cases of delay or failure are bone growth stimulator devices. By providing electric shocks to patients, they increase the normal pace of healing. Bone growth stimulation products, bone morphogenetic proteins, and platelet-rich plasma are some of the bone growth stimulators available on the market. Including pulsed electromagnetic field devices, capacitive coupling devices, and hybrid magnetic field devices, there are three types of bone growth stimulation devices.

Data Bridge Market Research analyses that the global bone growth stimulation devices market which was USD 965.06 million in 2022, would reach up to USD 1,397.83 million by 2030, and is expected to undergo a CAGR of 4.74% during the forecast period 2023-2030. “Hospitals and Clinics” dominates the end user segment of the global bone growth stimulation devices market owing to the availability of qualified professionals. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Bone Growth Stimulation Devices Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product (External Bone Growth Stimulators, Implanted Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators), Application (Spinal Fusion Surgeries, Delayed Union and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Other Applications), End User (Hospitals and Clinics, Home Care, Academic and Research Institutes and CROS)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa

Market Players Covered

Zimmer Biomet (U.S.), Bioventus (U.S.), Synergy Orthopedics (U.S.), Ito Co., Ltd. (Japan), DePuy Synthes (U.S.), DJO, LLC (U.S.), Ossatec Benelux BV (Netherlands), Orchid Medical, Inc. (U.S.), TERUMO BCT, INC. (U.S.), Arteriocyte Medical Systems, Inc. (U.S.), Arthrex, Inc. (U.S.), Smith & Nephew (U.K.), Stryker (U.S.), Medtronic (U.S.), Orthofix Medical Inc. (U.S.), Regen Lab SA (Switzerland), elizur Corporation (U.S.), BTT Health GmbH (Germany), Verve Consulting Inc. (U.S.) and IGEA (Italy)

Market Opportunities

  • Technological advancements
  • Customization and personalization

Market Definition

Bone growth stimulation devices are medical devices designed to enhance and accelerate the natural healing process of bones. They work by delivering low-level electrical or ultrasound signals to the site of a bone injury or fracture. These signals stimulate the cells responsible for bone regeneration, promoting the formation of new bone tissue. Bone growth stimulation devices are commonly used in orthopedic medicine to treat fractures that are slow to heal or conditions like non-unions and spinal fusion surgery. They can be applied externally or implanted internally, and they provide a non-invasive way to improve bone healing and reduce the need for additional surgical interventions.

Global Bone Growth Stimulation Devices Market Dynamics

Drivers

  • Rising Aging Population

As the global population continues to age, there is an increased prevalence of age-related bone conditions, fractures, and degenerative diseases like osteoporosis. This demographic trend boosts the demand for bone growth stimulation devices.

  • Increasing Incidence of Bone Fractures

Trauma-related injuries, accidents, and sports-related injuries contribute to a high incidence of bone fractures. Bone growth stimulation devices are often used to aid the healing process in these cases. This rising incidence of bone fractures and injuries act as a major driver for the growth of the global bone growth stimulation devices market.

Opportunities

  • Technological Advancements

As the global bone growth stimulation devices market grows, there will be increased investment in research and development. This can lead to the development of more advanced and effective devices, including those that are more patient-friendly, portable, and integrated with digital health technologies.

  • Customization and Personalization

There may be opportunities for customization and personalization of bone growth stimulation devices based on patient's specific needs. Tailored treatments and devices could lead to better patient outcomes.

Restraint/Challenge

  • Cost of Devices

Bone growth stimulation devices can be expensive, which can be a barrier to adoption for some patients and healthcare facilities. High costs can create a financial barrier for some patients, particularly those without comprehensive health insurance or those with high out-of-pocket expenses. This may lead to patients opting for alternative, potentially less effective treatments due to cost considerations.

This global bone growth stimulation devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global bone growth stimulation devices market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global bone growth stimulation devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global bone growth stimulation devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global bone growth stimulation devices market. The data is available for historic period 2015-2020.

Global Bone Growth Stimulation Devices Market Scope

The global bone growth stimulation devices market is segmented on the basis of product, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • External Bone Growth Stimulators
  • Implanted Bone Growth Stimulators
  • Ultrasonic Bone Growth Stimulators

Application

  • Spinal Fusion Surgeries
  • Delayed Union and Non-union Bone Fractures
  • Oral and Maxillofacial Surgeries
  • Other Applications

End User

  • Hospitals and Clinics
  • Home Care
  • Academic and Research Institutes
  • CROS

Global Bone Growth Stimulation Devices Market Regional Analysis/Insights

The global bone growth stimulation devices market is analyzed and market size insights and trends are provided by product, application and end user as referenced above.

The countries covered in the global bone growth stimulation devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the global bone growth stimulation devices market due to the high prevalence of osteoporosis or vertebral fractures

Asia-Pacific is expected to grow at the highest growth rate in the forecast period 2023-2030 due to the growing number of road accidents and trauma case along with large number of road accidents in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global bone growth stimulation devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global bone growth stimulation devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global bone growth stimulation devices market. The data is available for historic period 2015-2020. 

Competitive Landscape and Bone Growth Stimulation Devices Market Share Analysis

The global bone growth stimulation devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global bone growth stimulation devices market.

Some of the major players operating in the global bone growth stimulation devices market are:

  • Zimmer Biomet (U.S.)
  • Bioventus (U.S.)
  • Synergy Orthopedics (U.S.)
  • Ito Co., Ltd. (Japan)
  • DePuy Synthes (U.S.)
  • DJO, LLC (U.S.)
  • Ossatec Benelux BV (Netherlands)
  • Orchid Medical, Inc. (U.S.)
  • TERUMO BCT, INC. (U.S.)
  • Arteriocyte Medical Systems, Inc. (U.S.)
  • Arthrex, Inc. (U.S.)
  • Smith & Nephew (U.K.)
  • Stryker (U.S.)
  • Medtronic (U.S.)
  • Orthofix Medical Inc. (U.S.)
  • Regen Lab SA (Switzerland)
  • elizur Corporation (U.S.)
  • BTT Health GmbH (Germany)
  • Verve Consulting Inc. (U.S.)
  • IGEA (Italy)


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The rising aging population & increasing incidence of bone fractures are the growth drivers of the bone growth stimulation devices market.
The growth rate of the bone growth stimulation devices market is 4.74% in the forecast period by 2030.
The bone growth stimulation devices market size will be worth USD 1,397.83 million by 2030.
Product, application, and end-user are the factors on which the bone growth stimulation devices market research is based.
Major companies in the bone growth stimulation devices market are Zimmer Biomet (U.S.), Bioventus (U.S.), Synergy Orthopedics (U.S.), Ito Co., Ltd. (Japan), DePuy Synthes (U.S.), DJO, LLC (U.S.), Ossatec Benelux BV (Netherlands), Orchid Medical, Inc. (U.S.), TERUMO BCT, INC. (U.S.), Arteriocyte Medical Systems, Inc. (U.S.), Arthrex, Inc. (U.S.), Smith & Nephew (U.K.), Stryker (U.S.), Medtronic (U.S.), Orthofix Medical Inc. (U.S.), Regen Lab SA (Switzerland), elizur Corporation (U.S.), BTT Health GmbH (Germany), Verve Consulting Inc. (U.S.) and IGEA (Italy)